The stringent requirements of EU GMP Annex 1 present a major challenge for pharmaceutical manufacturers aiming to produce high-quality, safe medicinal products. Effectively achieving compliance involves a multifaceted https://www.14644.dk/practical-approaches-to-meeting-eu-gmp-annex-1-contamination-control-strategies